{"id":9004111222136438,"date":"2024-04-15T09:40:59","date_gmt":"2024-04-15T08:40:59","guid":{"rendered":"https:\/\/www.hgf.com\/?p=9004111222136438"},"modified":"2025-11-13T20:08:28","modified_gmt":"2025-11-13T20:08:28","slug":"enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques","status":"publish","type":"post","link":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/","title":{"rendered":"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques"},"content":{"rendered":"

Nous sommes heureux de f\u00e9liciter EnteroBiotix<\/a> pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9 pour les patients luttant contre des affections li\u00e9es \u00e0 l’intestin. Cette entreprise de biotechnologie de premier plan en phase clinique a r\u00e9ussi \u00e0 cl\u00f4turer une lev\u00e9e de fonds de 27 millions de livres sterling, avec le soutien d’investisseurs nouveaux et existants. <\/p>\n

Le financement sera utilis\u00e9 pour faire progresser leur principal candidat-produit EBX-102-02, alors qu’ils entament les essais cliniques de phase 2, qui cibleront le syndrome du c\u00f4lon irritable (SCI) en collaboration avec la prestigieuse Functional Gut Clinic. De plus, cela alimentera la progression des travaux d’EnteroBiotix sur le traitement d’un \u00e9ventail de conditions d\u00e9coulant de la dysbiose du microbiome intestinal, y compris la cirrhose du foie et l’enc\u00e9phalopathie h\u00e9patique (EH). <\/p>\n

Craig Thomson<\/a>, Associ\u00e9, a d\u00e9clar\u00e9 : \u00ab Ce fut un plaisir pour notre \u00e9quipe de PI sp\u00e9cialis\u00e9e dans le microbiome de travailler avec EnteroBiotix et nous sommes tous tr\u00e8s fiers de les aider \u00e0 s\u00e9curiser un portefeuille de PI solide et dynamique pour prot\u00e9ger ses actifs, ce qui joue un r\u00f4le important dans la stimulation de l’innovation. Nous sommes impatients de voir les d\u00e9veloppements positifs que cette avanc\u00e9e apportera. \u00bb<\/p>\n

Cliquez sur le bouton ci-dessous pour en savoir plus.<\/p>\n

EN SAVOIR PLUS<\/span><\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9 pour les patients luttant contre des affections li\u00e9es \u00e0 l’intestin. …<\/p>\n","protected":false},"author":473,"featured_media":9004111222136439,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[536,517],"tags":[],"class_list":["post-9004111222136438","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-centre-de-connaissances"],"acf":[],"yoast_head":"\nEnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques - HGF<\/title>\n<meta name=\"description\" content=\"Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques\" \/>\n<meta property=\"og:description\" content=\"Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9 pour les patients\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/\" \/>\n<meta property=\"og:site_name\" content=\"HGF\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-15T08:40:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T20:08:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hgf.com\/wp-content\/uploads\/2021\/06\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Katie Pilgrim\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hgf_ip\" \/>\n<meta name=\"twitter:site\" content=\"@hgf_ip\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katie Pilgrim\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/\"},\"author\":{\"name\":\"Katie Pilgrim\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/person\\\/c7c1ab6d978273ea223510a2f207dd04\"},\"headline\":\"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques\",\"datePublished\":\"2024-04-15T08:40:59+00:00\",\"dateModified\":\"2025-11-13T20:08:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/\"},\"wordCount\":268,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg\",\"articleSection\":[\"Articles\",\"Centre de connaissances\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/\",\"name\":\"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques - HGF\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg\",\"datePublished\":\"2024-04-15T08:40:59+00:00\",\"dateModified\":\"2025-11-13T20:08:28+00:00\",\"description\":\"Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/\",\"name\":\"HGF\",\"description\":\"Intellectual Property Rights specialists\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\",\"name\":\"HGF\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/hgf-logo-696x696-1.png\",\"contentUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/hgf-logo-696x696-1.png\",\"width\":696,\"height\":696,\"caption\":\"HGF\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hgf_ip\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hgf-limited-intellectual-property-specialists\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/person\\\/c7c1ab6d978273ea223510a2f207dd04\",\"name\":\"Katie Pilgrim\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b963facae8a3c7ba467afd3c9fd6b67ad50e4022d0eadc099f4ce6cb860808?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b963facae8a3c7ba467afd3c9fd6b67ad50e4022d0eadc099f4ce6cb860808?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b963facae8a3c7ba467afd3c9fd6b67ad50e4022d0eadc099f4ce6cb860808?s=96&d=mm&r=g\",\"caption\":\"Katie Pilgrim\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques - HGF","description":"Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/","og_locale":"fr_FR","og_type":"article","og_title":"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques","og_description":"Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9 pour les patients","og_url":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/","og_site_name":"HGF","article_published_time":"2024-04-15T08:40:59+00:00","article_modified_time":"2025-11-13T20:08:28+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2021\/06\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg","type":"image\/jpeg"}],"author":"Katie Pilgrim","twitter_card":"summary_large_image","twitter_creator":"@hgf_ip","twitter_site":"@hgf_ip","twitter_misc":{"\u00c9crit par":"Katie Pilgrim","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/#article","isPartOf":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/"},"author":{"name":"Katie Pilgrim","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/person\/c7c1ab6d978273ea223510a2f207dd04"},"headline":"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques","datePublished":"2024-04-15T08:40:59+00:00","dateModified":"2025-11-13T20:08:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/"},"wordCount":268,"publisher":{"@id":"https:\/\/www.hgf.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2021\/06\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg","articleSection":["Articles","Centre de connaissances"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/","url":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/","name":"EnteroBiotix limited obtient un financement de 27 millions de livres sterling pour faire progresser ses essais cliniques - HGF","isPartOf":{"@id":"https:\/\/www.hgf.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/#primaryimage"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2021\/06\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg","datePublished":"2024-04-15T08:40:59+00:00","dateModified":"2025-11-13T20:08:28+00:00","description":"Nous sommes heureux de f\u00e9liciter EnteroBiotix pour cette \u00e9tape importante dans leur parcours visant \u00e0 r\u00e9volutionner les soins de sant\u00e9.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/enterobiotix-limited-obtient-un-financement-de-27-millions-de-livres-sterling-pour-faire-progresser-ses-essais-cliniques\/#primaryimage","url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2021\/06\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg","contentUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2021\/06\/HGF_HealthcareScanner_Summer2021_1920x1080_05.jpg","width":1920,"height":1080},{"@type":"WebSite","@id":"https:\/\/www.hgf.com\/fr\/#website","url":"https:\/\/www.hgf.com\/fr\/","name":"HGF","description":"Intellectual Property Rights specialists","publisher":{"@id":"https:\/\/www.hgf.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hgf.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.hgf.com\/fr\/#organization","name":"HGF","url":"https:\/\/www.hgf.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-696x696-1.png","contentUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-696x696-1.png","width":696,"height":696,"caption":"HGF"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hgf_ip","https:\/\/www.linkedin.com\/company\/hgf-limited-intellectual-property-specialists\/"]},{"@type":"Person","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/person\/c7c1ab6d978273ea223510a2f207dd04","name":"Katie Pilgrim","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e3b963facae8a3c7ba467afd3c9fd6b67ad50e4022d0eadc099f4ce6cb860808?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e3b963facae8a3c7ba467afd3c9fd6b67ad50e4022d0eadc099f4ce6cb860808?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3b963facae8a3c7ba467afd3c9fd6b67ad50e4022d0eadc099f4ce6cb860808?s=96&d=mm&r=g","caption":"Katie Pilgrim"}}]}},"_links":{"self":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222136438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/users\/473"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/comments?post=9004111222136438"}],"version-history":[{"count":0,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222136438\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/media\/9004111222136439"}],"wp:attachment":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/media?parent=9004111222136438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/categories?post=9004111222136438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/tags?post=9004111222136438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}